TWD
FDMT icon

True Wealth Design’s 4D Molecular Therapeutics FDMT Stock Holding History

True Wealth Design’s Portfolio FDMT Stock Details FDMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$719 Hold
54
– – ﹤0.01% 2091
2026
Q1 		$503 Hold
54
– – ﹤0.01% 2050
2025
Q4 		$405 Hold
54
– – ﹤0.01% 2021
2025
Q3 		$470 Buy
+54
New +$323 ﹤0.01% 2029

Other funds holding FDMT

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
APW
Allied Private Wealth Boca Raton, Florida $156M AUM
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

True Wealth Design's FDMT Position: Q2 2026 in Review

True Wealth Design held its 4D Molecular Therapeutics (FDMT) position steady in Q2 2026 at 54 shares worth $719. The position accounts for ﹤0.01% of the portfolio, ranked #2091.

True Wealth Design first reported a position in FDMT in Q3 2025 and has held it in 4 quarters since. 9 funds tracked by Wall St. Rank hold FDMT as of Q2 2026.

  • True Wealth Design held 54 shares of 4D Molecular Therapeutics worth $719 as of Q2 2026.
  • True Wealth Design left its 4D Molecular Therapeutics share count unchanged in Q2 2026.
  • 4D Molecular Therapeutics made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #2091 holding.
  • True Wealth Design first reported a position in 4D Molecular Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 9 funds tracked by Wall St. Rank held 4D Molecular Therapeutics as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.